These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 32762901)

  • 1. Loop Diuretic Prescription and 30-Day Outcomes in Older Patients With Heart Failure.
    Faselis C; Arundel C; Patel S; Lam PH; Gottlieb SS; Zile MR; Deedwania P; Filippatos G; Sheriff HM; Zeng Q; Morgan CJ; Wopperer S; Nguyen T; Allman RM; Fonarow GC; Ahmed A
    J Am Coll Cardiol; 2020 Aug; 76(6):669-679. PubMed ID: 32762901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loop Diuretic Prescription and Long-Term Outcomes in Heart Failure: Association Modification by Congestion.
    Faselis C; Lam PH; Patel S; Arundel C; Filippatos G; Deedwania P; Zile MR; Wopperer S; Nguyen T; Allman RM; Fonarow GC; Ahmed A
    Am J Med; 2021 Jun; 134(6):797-804. PubMed ID: 33359271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining loop with thiazide diuretics in patients discharged home after a heart failure decompensation: Association with 30-day outcomes.
    Miró Ò; Núñez J; Trullàs JC; Lopez-Ayala P; Llauger L; Alquézar-Arbé A; Miñana G; Mollar A; de la Espriella R; Lorenzo M; Jacob J; Espinosa B; Garcés-Horna V; Aguirre A; Fortuny MJ; Martínez-Nadal G; Gil V; Mueller C; Llorens P; ; ;
    Eur J Intern Med; 2024 Sep; 127():126-133. PubMed ID: 38763846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF.
    DeVore AD; Hasselblad V; Mentz RJ; O'Connor CM; Armstrong PW; McMurray JJ; Ezekowitz JA; Tang WH; Starling RC; Voors AA; Califf RM; Hernandez AF
    Eur J Heart Fail; 2015 Mar; 17(3):340-6. PubMed ID: 25619549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Effect of Loop Diuretic Prescription on Mortality and Heart Failure Readmission.
    Virkud AV; Chang PP; Funk MJ; Kshirsagar AV; Edwards JK; Pate V; Kosorok MR; Gower EW
    Am J Cardiol; 2024 Jan; 210():208-216. PubMed ID: 37972425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiazide diuretics versus loop diuretics in stage 3-5 CKD: impact on cardiorenal outcomes.
    Sung LC; Chiu HW; Yu SM; Tsou LL; Hsu YH; Wu MS; Lin CL; Tsai FJ; Chou CL
    Postgrad Med; 2024 Sep; 136(7):738-748. PubMed ID: 39189768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loop diuretic use at discharge is associated with adverse outcomes in hospitalized patients with heart failure: a report from the Japanese cardiac registry of heart failure in cardiology (JCARE-CARD).
    Hamaguchi S; Kinugawa S; Tsuchihashi-Makaya M; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
    Circ J; 2012; 76(8):1920-7. PubMed ID: 22665070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
    Lam PH; Packer M; Gill GS; Wu WC; Levy WC; Zile MR; Brar V; Arundel C; Cheng Y; Singh SN; Allman RM; Fonarow GC; Ahmed A
    Am J Med; 2020 Oct; 133(10):1187-1194. PubMed ID: 32272101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes in patients treated with loop diuretics without a diagnosis of heart failure: a retrospective cohort study.
    Cuthbert JJ; Soyiri I; Lomax SJ; Turgoose J; Fuat A; Cohen J; Clark AL
    Heart; 2024 May; 110(12):854-862. PubMed ID: 38631899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On-treatment analysis of torsemide versus furosemide for patients hospitalized for heart failure: A post-hoc analysis of TRANSFORM-HF.
    Kittipibul V; Mentz RJ; Clare RM; Wojdyla DM; Anstrom KJ; Eisenstein EL; Ambrosy AP; Goyal P; Skopicki HA; Ketema F; Kim DY; Desvigne-Nickens P; Pitt B; Velazquez EJ; Greene SJ
    Eur J Heart Fail; 2024 Jul; 26(7):1518-1523. PubMed ID: 38745502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of short-acting vs. long-acting loop diuretics after heart failure hospitalization.
    Imaeda S; Shiraishi Y; Kohsaka S; Niimi N; Goda A; Nagatomo Y; Takei M; Saji M; Nakano S; Kohno T; Fukuda K; Yoshikawa T
    ESC Heart Fail; 2022 Oct; 9(5):2967-2977. PubMed ID: 35730147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.
    Damman K; Kjekshus J; Wikstrand J; Cleland JG; Komajda M; Wedel H; Waagstein F; McMurray JJ
    Eur J Heart Fail; 2016 Mar; 18(3):328-36. PubMed ID: 26693947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-Hospital Diuretic Agent Use and Post-Discharge Clinical Outcomes in Patients Hospitalized for Worsening Heart Failure: Insights From the EVEREST Trial.
    Mecklai A; Subačius H; Konstam MA; Gheorghiade M; Butler J; Ambrosy AP; Katz SD
    JACC Heart Fail; 2016 Jul; 4(7):580-588. PubMed ID: 27039131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of diuretic treatment at hospital discharge in patients with heart failure with all-cause short- and long-term mortality: A propensity score-matched analysis from SwedeHF.
    Parén P; Dahlström U; Edner M; Lappas G; Rosengren A; Schaufelberger M
    Int J Cardiol; 2018 Apr; 257():118-124. PubMed ID: 29506681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between changes in loop diuretic dose and outcomes in acute heart failure.
    Seko Y; Kato T; Morimoto T; Yaku H; Inuzuka Y; Tamaki Y; Ozasa N; Shiba M; Yamamoto E; Yoshikawa Y; Yamashita Y; Kitai T; Taniguchi R; Iguchi M; Nagao K; Kawai T; Komasa A; Nishikawa R; Kawase Y; Morinaga T; Toyofuku M; Furukawa Y; Ando K; Kadota K; Sato Y; Kuwahara K; Kimura T;
    ESC Heart Fail; 2023 Jun; 10(3):1757-1770. PubMed ID: 36858382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis.
    Täger T; Fröhlich H; Grundtvig M; Seiz M; Schellberg D; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L
    Int J Cardiol; 2019 Aug; 289():83-90. PubMed ID: 30827731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dapagliflozin on readmission and loop diuretics use in patients with acute heart failure: a retrospective propensity score-matched cohort study.
    Wu D; Ma Z; Wang X; Wang X; Wang X
    BMC Cardiovasc Disord; 2024 Aug; 24(1):402. PubMed ID: 39090542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discharge Diuretic Dose and 30-Day Readmission Rate in Acute Decompensated Heart Failure.
    Woodruff AE; Kelley AM; Hempel CA; Loeffler WJ; Echtenkamp CA; Hassan AK
    Ann Pharmacother; 2016 Jun; 50(6):437-45. PubMed ID: 26956954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry.
    Kapelios CJ; Laroche C; Crespo-Leiro MG; Anker SD; Coats AJS; Díaz-Molina B; Filippatos G; Lainscak M; Maggioni AP; McDonagh T; Mebazaa A; Metra M; Moura B; Mullens W; Piepoli MF; Rosano GMC; Ruschitzka F; Seferovic PM; Lund LH;
    Eur J Heart Fail; 2020 Aug; 22(8):1424-1437. PubMed ID: 32237110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between high-dose loop diuretic use at discharge and cardiovascular mortality in patients with heart failure.
    Okabe T; Yakushiji T; Kido T; Oyama Y; Igawa W; Ono M; Ebara S; Yamashita K; Yamamoto MH; Saito S; Amemiya K; Isomura N; Ochiai M
    ESC Heart Fail; 2018 Feb; 5(1):87-94. PubMed ID: 28967699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.